Andreas Nicholas J, Hyde Matthew J, Gale Chris, Parkinson James R C, Jeffries Suzan, Holmes Elaine, Modi Neena
Section of Neonatal Medicine, Department of Medicine, Chelsea & Westminster Hospital, Imperial College London, London, United Kingdom.
Section of Computational and Systems Medicine, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London, United Kingdom.
PLoS One. 2014 Dec 23;9(12):e115043. doi: 10.1371/journal.pone.0115043. eCollection 2014.
Maternal Body Mass Index (BMI) is positively associated with infant obesity risk. Breast milk contains a number of hormones that may influence infant metabolism during the neonatal period; these may have additional downstream effects on infant appetite regulatory pathways, thereby influencing propensity towards obesity in later life.
To conduct a systematic review of studies examining the association between maternal BMI and the concentration of appetite-regulating hormones in breast milk.
Pubmed was searched for studies reporting the association between maternal BMI and leptin, adiponectin, insulin, ghrelin, resistin, obestatin, Peptide YY and Glucagon-Like Peptide 1 in breast milk.
Twenty six studies were identified and included in the systematic review. There was a high degree of variability between studies with regard to collection, preparation and analysis of breast milk samples. Eleven of fifteen studies reporting breast milk leptin found a positive association between maternal BMI and milk leptin concentration. Two of nine studies investigating adiponectin found an association between maternal BMI and breast milk adiponectin concentration; however significance was lost in one study following adjustment for time post-partum. No association was seen between maternal BMI and milk adiponectin in the other seven studies identified. Evidence for an association between other appetite regulating hormones and maternal BMI was either inconclusive, or lacking.
A positive association between maternal BMI and breast milk leptin concentration is consistently found in most studies, despite variable methodology. Evidence for such an association with breast milk adiponectin concentration, however, is lacking with additional research needed for other hormones including insulin, ghrelin, resistin, obestatin, peptide YY and glucagon-like peptide-1. As most current studies have been conducted with small sample sizes, future studies should ensure adequate sample sizes and standardized methodology.
孕妇体重指数(BMI)与婴儿肥胖风险呈正相关。母乳中含有多种激素,可能会在新生儿期影响婴儿的新陈代谢;这些激素可能会对婴儿食欲调节途径产生额外的下游影响,从而影响其日后肥胖的倾向。
对研究孕妇BMI与母乳中食欲调节激素浓度之间关联的研究进行系统综述。
在PubMed上检索报告孕妇BMI与母乳中瘦素、脂联素、胰岛素、胃饥饿素、抵抗素、肥胖抑制素、肽YY和胰高血糖素样肽1之间关联的研究。
共识别出26项研究并纳入系统综述。在母乳样本的采集、制备和分析方面,各研究之间存在高度差异。在报告母乳瘦素的15项研究中,有11项发现孕妇BMI与母乳瘦素浓度呈正相关。在调查脂联素的9项研究中,有2项发现孕妇BMI与母乳脂联素浓度之间存在关联;然而,在一项研究中,产后时间调整后这种关联不再显著。在其他7项已识别的研究中,未发现孕妇BMI与母乳脂联素之间存在关联。关于其他食欲调节激素与孕妇BMI之间关联的证据要么不明确,要么缺乏。
尽管方法存在差异,但大多数研究一致发现孕妇BMI与母乳瘦素浓度呈正相关。然而,缺乏关于这种关联与母乳脂联素浓度的证据,对于包括胰岛素、胃饥饿素、抵抗素、肥胖抑制素、肽YY和胰高血糖素样肽1在内的其他激素,还需要更多研究。由于目前大多数研究样本量较小,未来的研究应确保足够的样本量和标准化的方法。